MedTrace Logo

Fibrin Sealant for Cholangiotomy Closure Study

NCT02545153 · Status: UNKNOWN · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 200

Last updated 2015-09-09

No results posted yet for this study

Summary

Bile leak reduction from the common bile duct, as a result of glue appliance after cholangiotomy.

Conditions

  • Common Bile Duct Gall Stones
  • Infection
  • Bile Leak

Interventions

DRUG

Tisseel, Baxter (Aprotinin and Fibrinogen)

After introducton of t tube and closure of the incision with running sutures, fibrin sealant is applied on the incision.

DRUG

Control

No fibrin sealant applied

Sponsors & Collaborators

  • Lasarettet i Enköping

    lead OTHER

Principal Investigators

  • Gabriel Sandblom, Assoc Prof · Karolinska Institutet

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-01-31
Primary Completion
2016-01-31
Completion
2016-12-31

Countries

  • Sweden

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02545153 on ClinicalTrials.gov